Great Point Partners LLC Portfolio Holdings

Great Point Partners LLC

  • $162 Million
  • Q1 2025

Great Point Partners LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $162 Million distributed in 32 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $14.9M, Kal Vista Pharmaceuticals, Inc. with a value of $11.7M, Evolus, Inc. with a value of $11.4M, Immunovant, Inc. with a value of $10.3M, and Viridian Therapeutics, Inc.\De with a value of $10.1M.

Examining the 13F form we can see an increase of $10.1M in the current position value, from $152M to 162M.

Great Point Partners LLC is based out at Greenwich, CT

Below you can find more details about Great Point Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $162 Million
Healthcare: $160 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.12B
$14.9 Million 9.19% of portfolio
370,000
Q1 2025 Added 2.78%
$345M
$11.7 Million 7.24% of portfolio
1,014,367
Q1 2025 Reduced 43.24%
$546M
$11.4 Million 7.03% of portfolio
944,743
Q1 2025 Added 5.5%
$3.55B
$10.3 Million 6.38% of portfolio
375,000
Q1 2025 New
$579M
$10.1 Million 6.25% of portfolio
750,000
Q3 2024 Added 50.0%
$2.57B
$9.98 Million 6.17% of portfolio
237,156
Q1 2025 Added 50.01%
$632M
$9.55 Million 5.9% of portfolio
4,973,840
Q1 2025 New
$1.96B
$8.23 Million 5.09% of portfolio
245,272
Q4 2024 New
$9.66B
$7.79 Million 4.82% of portfolio
50,000
Q1 2025 New
$1.3B
$7.73 Million 4.78% of portfolio
595,879
Q1 2025 Reduced 30.71%
$5.22B
$7.54 Million 4.66% of portfolio
250,000
Q1 2025 Reduced 50.5%
$300M
$6.41 Million 3.97% of portfolio
1,811,996
Q1 2025 New
$11.4M
$6.26 Million 3.87% of portfolio
10,980,000
Q4 2024 Added 28.29%
$6.3B
$4.69 Million 2.9% of portfolio
138,240
Q1 2025 New
$2.21B
$4.36 Million 2.7% of portfolio
115,517
Q1 2025 New
$218M
$4.23 Million 2.61% of portfolio
2,728,910
Q1 2025 Reduced 9.32%
$2.85B
$2.95 Million 1.82% of portfolio
45,000
Q1 2025 New
$337M
$2.87 Million 1.77% of portfolio
1,275,000
Q1 2025 Added 10.87%
$9.26M
$2.86 Million 1.77% of portfolio
4,683,711
Q4 2024 Reduced 32.46%
$172M
$2.42 Million 1.49% of portfolio
833,042
Q1 2025 Added 33.95%
$1.12B
$2.15 Million 1.33% of portfolio
149,702
Q1 2025 New
$138M
$2.12 Million 1.31% of portfolio
626,275
Q1 2025 Reduced 24.25%
$0
$1.85 Million 1.14% of portfolio
2,645,128
Q4 2024 Reduced 5.22%
$79.8M
$1.15 Million 0.71% of portfolio
850,000
Q1 2025 Reduced 19.43%
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Neurogene Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 6.37%
Abivax Sa
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 0.63%
Helix Acquisition Corp Ii
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 25.23%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 63.72%
Zura Bio LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 2.86%

Summary

  • Portfolio
  • No. of Stocks 32
  • Current Value $162 Million
  • Prior Value $152 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 9 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email